Collegium Rises As Cigna Turns To Xtampza In Fighting Opioid Abuse
October 05, 2017 at 16:00 PM EDT
Shares of Collegium Pharmaceutical are on the rise after health insurer Cigna announced that it will start covering the drugmaker's Xtampza ER, an extended-release oxycodone equivalent that cannot become more fast-acting through cutting or crushing.
